50岁以下人群晚期结直肠癌与症状持续时间或诊断时间较长无关
该回顾性研究比较了斯坦福癌症研究所2008年1月1日至2014年12月31日诊治的253例年轻发病(<50岁)与232例≥50岁结直肠癌患者,发现年轻组晚期肿瘤比例更高(72% vs 63%,P=0.03),且诊断时间、症状持续时间和评估时间均更长,但晚期患者症状和评估时间反而更短,提示肿瘤生物学可能是分期的重要决定因素。
要点
- 年轻发病结直肠癌患者晚期肿瘤比例高于老年患者(72% vs 63%,P=0.03)。
- 年轻患者诊断时间中位数128天 vs 老年患者79天(P<0.05),症状持续时间60天 vs 30天(P<0.01)。
- 年轻患者中III或IV期者症状持续时间和评估时间短于I或II期者。
核心结论
- 年轻发病结直肠癌患者诊断时晚期比例高于老年患者,该差异不能简单用症状出现至诊断的延迟解释。
- 肿瘤生物学可能是诊断分期的重要决定因素,临床医生应关注结直肠癌报警症状、家族史和遗传综合征以加快年轻患者评估和诊断。
- 能否识别可从早期筛查中获益的年轻发病结直肠癌高危亚组尚待确定。
研究设计与样本
- 回顾性研究,收集2008年1月1日至2014年12月31日在斯坦福癌症研究所诊治的经病理学家证实的结直肠腺癌患者数据。
- 比较年轻发病组(诊断年龄<50岁,n=253)与老年组(诊断年龄≥50岁,n=232)的症状、临床特征、诊断时间和癌症分期。
主要发现
- 年轻发病组晚期肿瘤比例为72%,老年组为63%(P=0.03)。
- 年轻发病组结直肠癌家族史比例为25%,老年组为17%(P=0.03)。
- 年轻发病组确诊或疑似遗传性癌症综合征比例为7%,老年组为1%(P<0.01)。
- 年轻发病组远端结肠癌比例为41%,老年组为34%(P=0.01);直肠癌比例为40%,老年组为35%(P=0.29)。
- 年轻发病组诊断时间中位数128天 vs 老年组79天(P<0.05),症状持续时间中位数60天 vs 30天(P<0.01),评估时间中位数31天 vs 22天(P<0.05)。
临床怎么用
- 作者认为,临床医生应关注结直肠癌报警症状、家族史和遗传综合征,以加快年轻患者的评估和诊断并可能改善结局。
- 作者指出,能否识别可从早期筛查中获益的年轻发病结直肠癌高危亚组尚待确定。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND & AIMS: The incidence of colorectal cancer (CRC) is increasing in the United States among adults younger than the age of 50 years. Studies of young-onset CRC have focused on outcomes and treatment patterns. We examined patient presentation, provider evaluation, and time to diagnosis, which can affect stage and prognosis. METHODS: In a retrospective study, we collected data from patients with a diagnosis of colorectal adenocarcinoma, confirmed by pathologists, seen at the Stanford Cancer Institute from January 1, 2008, through December 31, 2014. We compared symptoms, clinical features, time to diagnosis, and cancer stage in patients with young-onset CRC (diagnosed at an age younger than 50 years; n = 253) with patients diagnosed with CRC at an age of 50 years or older (n = 232). RESULTS: A higher proportion of patients with young-onset CRC were diagnosed with advanced-stage tumors (72%) compared with older patients (63%) (P = .03). Larger proportions of patients with young-onset CRC also had a family history of CRC (25% vs 17% in older patients; P = .03), confirmed or probable hereditary cancer syndromes (7% vs 1% in older patients; P < .01), and left-sided disease (distal colon cancer in 41% vs 34% in older patients; P = .01; and rectal cancer in 40% vs 35% in older patients; P = .29). Patients with young-onset CRC had a significantly longer median time to diagnosis (128 vs 79 days for older patients; P < .05), symptom duration (60 vs 30 days for older patients; P < .01), and time of evaluation (31 vs 22 days; P < .05). In multivariable analyses, time to diagnosis was 1.4-fold longer for younger than for older patients (P < .01). Among younger patients, those with stage III or IV CRC had shorter durations of symptoms and evaluations than those with stage I or II CRC. CONCLUSIONS: In a retrospective analysis of patients with CRC, we found that greater proportions of patients younger than 50 years were diagnosed with advanced-stage tumors than older patients; this difference could not be explained simply by delays from symptom onset to diagnosis. Although tumor biology may be an important determinant of stage at diagnosis, clinicians should be aware of CRC alarm symptoms, family history, and genetic syndromes, to speed evaluation and diagnosis of younger patients and potentially improve outcomes. It remains to be determined whether subgroups of persons at risk for young-onset CRC who benefit from early screening can be identified.
引用
- Chen FW, Sundaram V, Chew TA, et al. Advanced-Stage Colorectal Cancer in Persons Younger Than 50 Years Not Associated With Longer Duration of Symptoms or Time to Diagnosis. Clin Gastroenterol Hepatol. 2016. PMID: 27856366. doi:10.1016/j.cgh.2016.10.038
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。